← Leaderboards
Kimberly K. Scarsi
Northwestern University At Chicago
$1,715,023
Attributed
$1,715,023
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $306.8K · FY2012–20$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,715,023 · 2
By mechanism
R01$1,383,012 · 1
R21$332,011 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Neelesh A. Patankar$1,054,414
Others in their field
Top investigators on “Women&Apos”
- Steven T Dekosky · Rush University Medical Center$18,932,347
- Jose A Luchsinger · Columbia University Health Sciences$16,383,484
- Corette B Parker · Research Triangle Institute$14,403,014
- Kejal Kantarci · Mayo Clinic Rochester$8,220,660
- George R. Saade · Research Triangle Institute$7,301,796
- Philip Greenland · Research Triangle Institute$7,301,796
Research focus
Women&AposMorbidity - Disease RateChild MortalityFertilityMaternal MortalityDrug KineticsEfavirenzFamily PlanningCountryAfrica South Of The SaharaLevonorgestrelImplantAntiretroviral TherapyDrug InteractionsFemale Of Child Bearing AgeAreaEvidence BaseExcisionBaseControl GroupsContraceptive AgentsContraceptive EfficacyContraceptive MethodsHormones
Grant awards (8)
Pharmacological Strategies to use the Levonorgestrel Implant in HIV-infected Women$274,666
R01 · FY2020 · HD · contact PI
Pharmacological Strategies to use the Levonorgestrel Implant in HIV-infected Women$267,072
R01 · FY2019 · HD · contact PI
Pharmacological Strategies to use the Levonorgestrel Implant in HIV-infected Women$267,308
R01 · FY2018 · HD · contact PI
Pharmacological Strategies to use the Levonorgestrel Implant in HIV-infected Women$267,211
R01 · FY2017 · HD · contact PI
Pharmacological Strategies to use the Levonorgestrel Implant in HIV-infected Women$306,755
R01 · FY2015 · HD · contact PI
A Pharmacokinetic evaluation of levonorgestrel implant and antiretrovial therapy$115,166
R21 · FY2013 · HD · contact PI
A pharmacokinetic evaluation of levonorgestrel implant and antiretroviral therapy$66,111
R21 · FY2013 · HD · contact PI
A pharmacokinetic evaluation of levonorgestrel implant and antiretroviral therapy$150,734
R21 · FY2012 · HD · contact PI